scout
Opinion|Videos|December 6, 2023

Other Therapies Approved for Patients With MF

Dr Anthony Hunter reviews the other three approved JAK inhibitors for treatment of myelofibrosis: ruxolitinib, fedratinib, and pacritinib.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME